InvestorsHub Logo
Followers 49
Posts 9775
Boards Moderated 1
Alias Born 01/31/2008

Re: Investor2014 post# 182609

Friday, 02/22/2019 11:11:16 AM

Friday, February 22, 2019 11:11:16 AM

Post# of 458346
The question is could Anavex have attracted an even better CEO for less money?

I seriously doubt it. Show me another small biotech CEO (under $1 billion market cap) who has:

1. Chemistry PhD to understand the science

2. Top business school Northwestern MBA to understand business strategy.

3. Previous CFO experience to understand company finance.

4. Wall Street investment banker small cap experience to understand how to fight off the short snakes and vipers.

5. A super ability to attract the best in the world to his scientific advisory board.

6. An unsurpassed ability to get others to finance our trials, thus minimizing dilution.

7. A visionary who is leading the effort to bring precision medicine to drug trials.

Most small biotech CEOS can't even tick 4 out of 7 of these boxes. Missling is 7 of 7.

You just have to look at the 4 clown CEOs in a row that ADXS has, to realize how blessed AVXL is to have Missling.

And he doesn't cost much in cash compensation, and most of his options have strike prices in the $6-8 range. So he won't make much until he drives the stock price up substantially.




You have to ask yourself, "Do I feel lucky?" Well, do you short punk?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News